NO990909L - Farmas°ytisk sammensetning inneholdende lornoxicam og et dinatriumsalt av EDTA - Google Patents

Farmas°ytisk sammensetning inneholdende lornoxicam og et dinatriumsalt av EDTA

Info

Publication number
NO990909L
NO990909L NO990909A NO990909A NO990909L NO 990909 L NO990909 L NO 990909L NO 990909 A NO990909 A NO 990909A NO 990909 A NO990909 A NO 990909A NO 990909 L NO990909 L NO 990909L
Authority
NO
Norway
Prior art keywords
edta
composition containing
disodium salt
surface composition
lornoxicam
Prior art date
Application number
NO990909A
Other languages
English (en)
Other versions
NO326350B1 (no
NO990909D0 (no
Inventor
Hermann Ruckendorfer
Philippus Egger
Original Assignee
Nycomed Austria Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Austria Gmbh filed Critical Nycomed Austria Gmbh
Publication of NO990909L publication Critical patent/NO990909L/no
Publication of NO990909D0 publication Critical patent/NO990909D0/no
Publication of NO326350B1 publication Critical patent/NO326350B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19990909A 1996-09-03 1999-02-25 Farmasoytisk sammensetning inneholdende lornoxicam og et dinatriumsalt av EDTA NO326350B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0156496A ATA156496A (de) 1996-09-03 1996-09-03 Pharmazeutische zusammensetzung
PCT/EP1997/004742 WO1998009654A1 (de) 1996-09-03 1997-09-01 Pharmazeutische zusammensetzung enthaltend lornoxicam und ein dinatriumsalz der edta

Publications (3)

Publication Number Publication Date
NO990909L true NO990909L (no) 1999-02-25
NO990909D0 NO990909D0 (no) 1999-02-25
NO326350B1 NO326350B1 (no) 2008-11-17

Family

ID=3516134

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990909A NO326350B1 (no) 1996-09-03 1999-02-25 Farmasoytisk sammensetning inneholdende lornoxicam og et dinatriumsalt av EDTA

Country Status (12)

Country Link
EP (1) EP0934079B1 (no)
JP (1) JP4122062B2 (no)
CN (1) CN1108822C (no)
AT (2) ATA156496A (no)
AU (1) AU4552597A (no)
CA (1) CA2264626C (no)
DE (1) DE59706450D1 (no)
DK (1) DK0934079T3 (no)
ES (1) ES2172002T3 (no)
NO (1) NO326350B1 (no)
PT (1) PT934079E (no)
WO (1) WO1998009654A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001172183A (ja) * 1999-12-21 2001-06-26 Wakamoto Pharmaceut Co Ltd 眼科用医薬組成物
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
JO2735B1 (en) 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formulations of palonosetron
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
CN100560058C (zh) * 2006-05-23 2009-11-18 姚俊华 一种口服、快速起效的镇痛药物
ES3037313T3 (en) 2009-10-12 2025-09-30 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
MX2012010077A (es) 2010-03-03 2012-09-12 Boehringer Ingelheim Vetmed Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
WO2012127496A1 (en) 2011-03-01 2012-09-27 Cadila Healthcare Limited Stable pharmaceutical compositions of lornoxicam or salts thereof
CN106727364B (zh) * 2016-12-02 2020-01-24 苏州天马医药集团天吉生物制药有限公司 一种注射用氯诺昔康的冻干工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1203703B (it) * 1983-05-23 1989-02-15 Bruschettin Srl Composizione farmaceutica a carattere di collirio ad azione antiinfiammatoria,e procedimento per la sua preparazione
US5362758A (en) * 1992-09-18 1994-11-08 Pfizer Inc. Ophthalmic piroxicam solution
AU5774796A (en) * 1995-06-13 1997-01-09 Dyer, Alison Margaret Pharmaceutical compositions containing lornoxicam and cyclod extrin

Also Published As

Publication number Publication date
NO326350B1 (no) 2008-11-17
EP0934079A1 (de) 1999-08-11
CN1228710A (zh) 1999-09-15
CN1108822C (zh) 2003-05-21
NO990909D0 (no) 1999-02-25
PT934079E (pt) 2002-06-28
AU4552597A (en) 1998-03-26
DE59706450D1 (de) 2002-03-28
WO1998009654A1 (de) 1998-03-12
ES2172002T3 (es) 2002-09-16
DK0934079T3 (da) 2002-04-02
CA2264626A1 (en) 1998-03-12
JP4122062B2 (ja) 2008-07-23
JP2000517331A (ja) 2000-12-26
EP0934079B1 (de) 2002-02-20
ATE213420T1 (de) 2002-03-15
ATA156496A (de) 1997-10-15
CA2264626C (en) 2009-03-24

Similar Documents

Publication Publication Date Title
EE9800187A (et) Trombiini inhibiitorite eelravimid
NO965327D0 (no) Sporbare brönnsementsammensetninger og metoder
NO990909L (no) Farmas°ytisk sammensetning inneholdende lornoxicam og et dinatriumsalt av EDTA
LV12102A (lv) Rotamazes funkciju inhibitori
BR9607791A (pt) Formulação oral de 2-metil-tieno-benzodiazepina
PL324527A1 (en) Cyclic inhibitors of gmp-specific phosphodisterase
PL322904A1 (en) Sulphonamidic inhibitors of aspartil protease containing oxidated heterocyclic group
NO974495L (no) Forbindelse og sammensetninger for levering av aktive midler
PL322877A1 (en) Sulphonamidic inhibitors of aspartil hiv protease containing thf
NO954056L (no) Kombinasjon av laser tracker og kamerabasert koordinatmåling
DK42093D0 (da) Administrationsmetode
MX9205725A (es) Formulaciones generantes de gas no azidico
DK516487A (da) Laegemiddel indholdende en kombination af angiotensin-converting-enzyme-inhibitorer og calciumantagonister
DE69412842D1 (de) Endodontisches instrument vorbestimmter flexibilität
DE69620161D1 (de) Thrombininhibitoren
FI960803L (fi) TNF-alfa-sekreetion inhibiittoreita
IS1821B (is) Samsetning 5-HT upptöku-hemils og valkvæðs 5-HT 1A -mótlyfs
BR9407743A (pt) Composiçao oral de peróxido de cálcio-bicarbonato
FR2686425B1 (fr) Source sismique de puits.
PY0101314A (es) Compuestos farmaceuticos
IT1276799B1 (it) Formulazioni di f-silicone
FI943102A7 (fi) Laite kuonan vesirakeistamista varten
NO924528L (no) Derivater av humant gallesalt-stimulert lipase og farmasoeytiske sammensetninger som inneholder disse
FI860444A7 (fi) Kromogeenisia aineita tai kromogeenisten aineiden ja peroksidien seoksia sisältäviä pysyviä kemiallisia koostumuksia ja menetelmiä pysyvien kemiallisten koostumsten muodostamiseksi.
KR970000226A (ko) S-이부프로펜의 경구용 제형

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA PHARMA A/S, DK

MK1K Patent expired